查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1584127

癌症护理市场中的基因组学，按测试类型、按技术类型、按应用、按最终用户、按国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Genomics in Cancer Care Market, By Test Type, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，基因体学在癌症护理市场规模为1812,032万美元，2024年至2032年复合年增长率为16.10%。

癌症护理市场中的基因组学-市场动态

对个人化医疗的日益重视推动基因组学在癌症护理市场的发展

对个人化医疗的日益重视正在显着推动基因组学在癌症护理市场的发展，美国国家癌症研究所的研究结果证明，基于基因组分析的定制治疗可以改善超过 30% 的癌症病例的患者预后。美国临床肿瘤学会 (ASCO) 等组织主张将基因组资料整合到治疗决策中，促进专门针对肿瘤基因突变的精准疗法的开发。此外，大型倡议，例如美国国立卫生研究院的“我们所有人研究计划”，旨在从不同人群收集广泛的基因组资料，以更好地了解遗传因素如何影响癌症和治疗效果。因此，个人化医疗正在从概念转变为实践，基因组测试越来越多地在临床环境中采用，以确定对个别患者最有效的治疗方法，最终导致更好的癌症护理管理并提高生存率。

癌症护理市场中的基因组学 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 16.10% 左右的复合年增长率成长

根据测试类型细分，预计种系基因组学测试将在 2023 年显示最大的市场份额

根据技术类型细分，二代定序（NGS）是2023年的主导类型

从应用细分来看，个人化医疗是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

癌症护理市场中的基因组学 - 細項分析：

全球癌症护理市场基因组学根据测试类型、技术类型、应用、最终用户和地区进行细分。

根据测试类型，市场分为两类：种系基因组测试和体细胞基因组测试。种系基因组学测试因其在识别遗传性癌症风险和告知预防策略方面的关键作用而排名最高。体细胞基因组学测试重点关注肿瘤特异性突变，为癌症护理中的个人化治疗选择提供重要见解。

根据技术类型，市场分为四类：次世代定序、PCR、微阵列和 CRISPR。新一代定序 (NGS) 拥有最高优先级，因为它能够有效分析大量基因组资料。接下来是 PCR，广泛用于标靶扩增。微阵列技术排名第三，而CRISPR虽然具有创新性，但在临床应用中仍处于新兴阶段。

癌症护理市场中的基因组学 - 地理洞察

在先进的医疗基础设施和研发方面的大量投资的推动下，北美在癌症护理市场的基因组学方面占据主导地位。美国国家癌症研究所报告称，基因组检测可以指导近 50% 癌症患者的治疗，凸显了其在精准医疗中的关键作用。欧洲紧随其后，德国和英国等国家实施了强有力的基因组医学计划，例如英国国民健康服务 (NHS) 基因组项目，旨在将基因组测试纳入超过 500 万名患者的常规癌症护理中。在亚太地区，中国和日本等国家正迅速采用基因组技术；中国「十三五」规划强调发展生物技术，计画加大对基因体研究和应用的投入。拉丁美洲正在逐步改善基因组检测的可近性，巴西卫生部正在推动将基因组学纳入癌症治疗指南的措施。同时，中东和非洲正致力于加强医疗基础设施以支持基因组医学，这反映出人们越来越致力于透过创新的基因组方法来应对癌症。

癌症护理市场中的基因组学-竞争格局：

癌症护理市场基因组学的竞争格局主要由北美主导，Illumina 和 Thermo Fisher Scientific 等主要参与者推动创新。 2023年，Illumina推出了Illumina NextSeq 2000系统，显着增强了癌症诊断和研究的基因组定序能力。在欧洲，罗氏是一个强大的竞争对手，积极与各种医疗机构合作，将基因组测试整合到临床实践中，从而改善患者的治疗结果。罗氏与 Genomics England 计画的合作旨在分析 10 万名癌症患者的基因组资料，为个人化治疗策略铺平道路。同时，在亚太地区，华大基因集团正在取得显着进展，开发了DNBSEQ平台来促进大规模基因组研究。此外，Illumina收购Grail也巩固了其在早期癌症检测市场的地位，利用液体活检技术提高诊断精度。这种竞争环境展示了利用基因组进步彻底改变全球癌症照护的承诺，透过合作和创新塑造肿瘤学的未来。

最新进展：

2024 年 9 月，印度癌症基因组图谱 (ICGA) 最近推出了癌症多组学资料门户，这是印度首个此类资料门户。该入口网站提供乳癌患者资料的访问，包括他们的 DNA、RNA 和蛋白质概况、治疗历史和患者结果。 ICGA 的目标是创建印度特有的数据集，以帮助研究人员和临床医生开发个人化的癌症治疗方法。

2024 年 9 月，英国首个机器人基因组测试设施在皇家马斯登 NHS 基金会信託基金启动，以加强癌症患者护理。这种自动化将使测试能力加倍，简化流程，并透过识别遗传风险和突变来改善获得个人化治疗的机会。

目录

第 1 章：癌症护理市场中的基因组学概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按测试类型分類的癌症护理市场基因组学片段
    • 按技术类型分類的癌症护理市场基因组学片段
    • 基因组学在癌症护理市场的应用片段
    • 最终用户的癌症护理市场基因组学片段
    • 按国家/地区分類的癌症护理市场基因组学片段
    • 按地区分類的癌症护理市场基因组学片段
  • 竞争洞察

第 3 章：癌症治疗中的基因组学主要市场趋势

  • 癌症护理市场驱动因素中的基因组学
    • 市场驱动因素的影响分析
  • 癌症治疗市场限制中的基因组学
    • 市场限制影响分析
  • 癌症护理市场机会中的基因组学
  • 癌症治疗市场的基因组学未来趋势

第 4 章：癌症护理产业研究中的基因组学

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：癌症护理市场中的基因组学：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：癌症护理市场格局中的基因组学

  • 癌症护理市场份额分析中的基因组学，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：癌症护理市场中的基因组学 - 按测试类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 种系基因组学测试
    • 体细胞基因体学检测

第 8 章：癌症护理市场中的基因组学 - 按技术类型

  • 概述
    • 按技术类型分類的细分市场份额分析
    • 新一代定序 (NGS)
    • 聚合酶炼式反应
    • 微阵列
    • 基因编辑技术

第 9 章：癌症护理市场中的基因组学 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 生物标记发现
    • 个人化医疗
    • 药物发现与开发
    • 临床诊断

第 10 章：癌症护理市场中的基因组学 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊断实验室
    • 研究所
    • 製药与生物技术公司

第 11 章：癌症护理市场中的基因组学 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 癌症护理中的基因组学北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按技术类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 癌症治疗中的基因组学欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模和预测（按技术类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 癌症治疗中的基因组学亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 按测试类型分類的亚太市场规模和预测
    • 亚太地区市场规模与预测（依技术类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 癌症护理中的基因组学拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按测试类型）
    • 拉丁美洲市场规模与预测（按技术类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 癌症治疗中的基因组学 中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模及预测（依技术类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：关键供应商分析 - 癌症护理产业中的基因组学

  • 竞争仪表板
  • 公司简介
    • Adaptive Biotechnologies Corporation
    • Agilent Technologies, Inc.
    • BGI Group
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Foundation Medicine, Inc. (Roche)
    • Genomic Health, Inc. (Exact Sciences)
    • Guardant Health, Inc.
    • Illumina, Inc.
    • Myriad Genetics, Inc.
    • NeoGenomics, Inc.
    • Oxford Nanopore Technologies Ltd.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer, Inc.
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4110

REPORT HIGHLIGHT

Genomics in Cancer Care Market size was valued at USD 18,120.32 Million in 2023, expanding at a CAGR of 16.10% from 2024 to 2032.

The Genomics in Cancer Care Market encompasses the application of genomic technologies to enhance cancer diagnosis, treatment, and prevention strategies. With the increasing understanding of the genetic basis of cancer, there is a growing emphasis on personalized medicine, which has led to significant advancements in genomics. A report from the National Cancer Institute indicated that genomic testing could improve treatment outcomes for over 40% of cancer patients by identifying specific mutations. The rising prevalence of cancer globally, coupled with the growing demand for precision therapies, is boosting market growth. However, challenges such as high costs associated with genomic testing and a lack of standardized guidelines may restrain widespread adoption. Additionally, ethical concerns surrounding genetic data usage present barriers to market expansion. Opportunities are emerging in the development of innovative genomic technologies, such as liquid biopsies and next-generation sequencing, which are transforming cancer diagnostics and treatment approaches. These advancements are expected to enhance patient outcomes and drive the future of cancer care.

Genomics in Cancer Care Market- Market Dynamics

Growing Emphasis on Personalized Medicine Propels the Genomics in Cancer Care Market

The growing emphasis on personalized medicine is significantly propelling the Genomics in Cancer Care Market, as evidenced by the National Cancer Institute's findings that tailored treatments based on genomic profiling can improve patient outcomes in over 30% of cancer cases. Organizations like the American Society of Clinical Oncology (ASCO) advocate for the integration of genomic data in treatment decision-making, promoting the development of precision therapies that specifically target genetic mutations in tumors. Additionally, large-scale initiatives, such as the All of Us Research Program by the National Institutes of Health, aim to gather extensive genomic data from diverse populations to better understand how genetic factors influence cancer and treatment efficacy. As a result, personalized medicine is transitioning from concept to practice, with genomic tests being increasingly adopted in clinical settings to identify the most effective treatments for individual patients, ultimately leading to better management of cancer care and improved survival rates.

Genomics in Cancer Care Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.10% over the forecast period (2024-2032)

Based on Test Type segmentation, Germline genomics testing was predicted to show maximum market share in the year 2023

Based on Technology Type segmentation, Next-Generation Sequencing (NGS) was the leading type in 2023

Based on Application segmentation, Personalized Medicine was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Genomics in Cancer Care Market- Segmentation Analysis:

The Global Genomics in Cancer Care Market is segmented on the basis of Test Type, Technology Type, Application, End-User, and Region.

The market is divided into two categories based on Test Type: Germline Genomics Testing, and Somatic Genomics Testing. Germline genomics testing ranks highest due to its critical role in identifying hereditary cancer risks and informing prevention strategies. Somatic genomics testing follows as it focuses on tumor-specific mutations, providing essential insights for personalized treatment options in cancer care.

The market is divided into four categories based on Technology Type: Next-Generation Sequencing, PCR, Microarray, and CRISPR. Next-Generation Sequencing (NGS) holds the highest priority due to its ability to analyze vast amounts of genomic data efficiently. PCR follows, widely used for targeted amplification. Microarray technology ranks third, while CRISPR, although innovative, is still emerging in clinical applications.

Genomics in Cancer Care Market- Geographical Insights

North America dominates the Genomics in Cancer Care Market, driven by advanced healthcare infrastructure and significant investments in research and development. The U.S. National Cancer Institute reported that genomic testing could guide treatment for nearly 50% of cancer patients, highlighting its critical role in precision medicine. Europe follows closely, with countries like Germany and the UK implementing robust genomic medicine initiatives, such as the Genomic UK National Health Service (NHS) project, aiming to integrate genomic testing into routine cancer care for over 5 million patients. In the Asia-Pacific region, countries like China and Japan are rapidly adopting genomic technologies; China's 13th Five-Year Plan emphasizes the development of biotechnology, with plans to increase investment in genomic research and application. Latin America is gradually improving access to genomic testing, with Brazil's Ministry of Health promoting initiatives to incorporate genomics into cancer treatment guidelines. Meanwhile, the Middle East & Africa are focusing on enhancing healthcare infrastructure to support genomic medicine, reflecting a growing commitment to tackling cancer through innovative genomic approaches.

Genomics in Cancer Care Market- Competitive Landscape:

The competitive landscape of the Genomics in Cancer Care Market is primarily led by North America, with key players like Illumina and Thermo Fisher Scientific driving innovation. In 2023, Illumina launched its Illumina NextSeq 2000 system, which significantly enhances genomic sequencing capabilities for cancer diagnostics and research. In Europe, Roche is a formidable competitor, actively collaborating with various healthcare institutions to integrate genomic testing into clinical practices, thus improving patient outcomes. Roche's partnership with the Genomics England initiative aims to analyze genomic data from 100,000 cancer patients, paving the way for personalized treatment strategies. Meanwhile, in the Asia-Pacific region, BGI Group is making notable advancements, having developed the DNBSEQ platform to facilitate large-scale genomic studies. Additionally, the acquisition of Grail by Illumina has reinforced its position in the early cancer detection market, utilizing liquid biopsy technology to enhance diagnostic precision. This competitive environment showcases a commitment to leveraging genomic advancements to revolutionize cancer care globally, with collaborations and innovations shaping the future of oncology.

Recent Developments:

In September 2024, The Indian Cancer Genome Atlas (ICGA) recently launched a multi-omics data portal for cancer, which is the first of its kind in India. The portal provides access to data on breast cancer patients, including their DNA, RNA, and protein profiles, treatment histories, and patient outcomes. The ICGA's goal is to create datasets specific to India to help researchers and clinicians develop personalized cancer treatments.

In September 2024, The UK's first robotic genomic testing facility was launched at The Royal Marsden NHS Foundation Trust, enhancing cancer patient care. This automation will double testing capacity, streamline processes, and improve access to personalized treatments by identifying genetic risks and mutations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMICS IN CANCER CARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Foundation Medicine, Inc. (Roche)
  • Genomic Health, Inc. (Exact Sciences)
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Germline Genomics Testing
  • Somatic Genomics Testing

GLOBAL GENOMICS IN CANCER CARE MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • PCR
  • Microarray
  • CRISPR

GLOBAL GENOMICS IN CANCER CARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Biomarker Discovery
  • Personalized Medicine
  • Drug Discovery & Development
  • Clinical Diagnostics

GLOBAL GENOMICS IN CANCER CARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical & Biotechnology Companies

GLOBAL GENOMICS IN CANCER CARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomics in Cancer Care Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomics in Cancer Care Market Snippet by Test Type
    • 2.1.2. Genomics in Cancer Care Market Snippet by Technology Type
    • 2.1.3. Genomics in Cancer Care Market Snippet by Application
    • 2.1.4. Genomics in Cancer Care Market Snippet by End-User
    • 2.1.5. Genomics in Cancer Care Market Snippet by Country
    • 2.1.6. Genomics in Cancer Care Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomics in Cancer Care Key Market Trends

  • 3.1. Genomics in Cancer Care Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomics in Cancer Care Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomics in Cancer Care Market Opportunities
  • 3.4. Genomics in Cancer Care Market Future Trends

4. Genomics in Cancer Care Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomics in Cancer Care Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomics in Cancer Care Market Landscape

  • 6.1. Genomics in Cancer Care Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomics in Cancer Care Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Germline Genomics Testing
    • 7.1.3. Somatic Genomics Testing

8. Genomics in Cancer Care Market - By Technology Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. PCR
    • 8.1.4. Microarray
    • 8.1.5. CRISPR

9. Genomics in Cancer Care Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Biomarker Discovery
    • 9.1.3. Personalized Medicine
    • 9.1.4. Drug Discovery & Development
    • 9.1.5. Clinical Diagnostics

10. Genomics in Cancer Care Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes
    • 10.1.5. Pharmaceutical & Biotechnology Companies

11. Genomics in Cancer Care Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Genomics in Cancer Care Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Genomics in Cancer Care Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Genomics in Cancer Care Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Genomics in Cancer Care Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Genomics in Cancer Care Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Genomics in Cancer Care Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Adaptive Biotechnologies Corporation
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. BGI Group
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. F. Hoffmann-La Roche AG
    • 12.2.6. Foundation Medicine, Inc. (Roche)
    • 12.2.7. Genomic Health, Inc. (Exact Sciences)
    • 12.2.8. Guardant Health, Inc.
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Myriad Genetics, Inc.
    • 12.2.11. NeoGenomics, Inc.
    • 12.2.12. Oxford Nanopore Technologies Ltd.
    • 12.2.13. Pacific Biosciences of California, Inc.
    • 12.2.14. PerkinElmer, Inc.
    • 12.2.15. Qiagen N.V.
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us